|
| 37468718 | Increasing access to quality healthcare for children who are incarcerated: American Pediatric Society issue of the year (2023-2024). | Pediatr Res | 2024 |
| 38071276 | Time-sensitive healthcare guidelines for youth with chronic diseases in custody: gaps in care. | Pediatr Res | 2024 |
| 37883803 | Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease. | Blood Adv | 2024 |
| 36322937 | Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial. | Blood | 2023 |
| 37756514 | Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries. | Blood Adv | 2023 |
| 37595029 | A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD. | Blood Adv | 2023 |
| 38066894 | The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally. | Hematology Am Soc Hematol Educ Program | 2023 |
| 37793767 | Sickle cell disease strategies and priorities - Authors' reply. | Lancet Haematol | 2023 |
| 37736971 | Epidemiology of Maternal Nutritional Status and Risk of Adverse Birth Outcomes in Undernourished Mothers with Sickle Cell Disease: A Systematic Review and Meta-Analysis Protocol. | Methods Protoc | 2023 |
| 37494609 | Barriers and Facilitators of Premarital Genetic Counseling for Sickle Cell Disease in Northern Nigeria. | J Pediatr Hematol Oncol | 2023 |
| 37461538 | Barriers and Facilitators to a Task-Shifted Stroke Prevention Program for Children with Sickle Cell Anemia in a Community Hospital: A Qualitative Study. | Res Sq | 2023 |
| 37387218 | Toward Automated Detection of Silent Cerebral Infarcts in Children and Young Adults With Sickle Cell Anemia. | Stroke | 2023 |
| 37451304 | Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. | Lancet Haematol | 2023 |
| 37428866 | Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria. | Blood Adv | 2023 |
| 37064181 | Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume. | Front Neurol | 2023 |
| 36883847 | The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease. | Blood Adv | 2023 |
| 36799926 | Most adults with severe HbSC disease are not treated with hydroxyurea. | Blood Adv | 2023 |
| 36383708 | Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting. | Blood Adv | 2023 |
| 36350716 | Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy. | Blood Adv | 2023 |
| 32882704 | The american pediatric society and society for pediatric research joint statement against racism and social injustice. | Pediatr Res | 2022 |
| 35700018 | Primary Prevention of Stroke in Children With Sickle Cell Anemia in Nigeria: Protocol for a Mixed Methods Implementation Study in a Community Hospital. | JMIR Res Protoc | 2022 |
| 35816686 | Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease. | Blood Adv | 2022 |
| 35816639 | Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis. | Blood Adv | 2022 |
| 35683502 | Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies. | J Clin Med | 2022 |
| 36485167 | Acute pain episodes, acute chest syndrome, and pulmonary thromboembolism in pregnancy. | Hematology Am Soc Hematol Educ Program | 2022 |
| 36485155 | Epidemiology and treatment of priapism in sickle cell disease. | Hematology Am Soc Hematol Educ Program | 2022 |
| 36170507 | Sickle Cell Disease and Gene Therapy - Patient and Physician Perspectives. | N Engl J Med | 2022 |
| 36170252 | Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease. | Proc Natl Acad Sci U S A | 2022 |
| 36196180 | PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE-PART II. | Trans Am Clin Climatol Assoc | 2022 |
| 36291335 | Effect of Blood Transfusion on Cerebral Hemodynamics and Vascular Topology Described by Computational Fluid Dynamics in Sickle Cell Disease Patients. | Brain Sci | 2022 |
| 33560078 | Psychometric Impact of Priapism on Lives of Adolescents and Adults With Sickle Cell Anemia: A Sequential Independent Mixed-Methods Design. | J Pediatr Hematol Oncol | 2022 |
| 35015811 | Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis. | Blood Adv | 2022 |
| 34983646 | Translating research to usual care of children with sickle cell disease in Northern Nigeria: lessons learned from the SPRING Trial Team. | BMC Res Notes | 2022 |
| 34971579 | Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. | Lancet Haematol | 2022 |
| 35196384 | Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting. | Blood Adv | 2022 |
| 34389800 | Correction: The american pediatric society and society for pediatric research joint statement against racism and social injustice. | Pediatr Res | 2022 |
| 34103680 | Academic pipeline initiatives in pediatrics. | Pediatr Res | 2022 |
| 34001783 | Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework. | J Pediatr Hematol Oncol | 2022 |
| 33236662 | Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial. | Pediatr Hematol Oncol | 2021 |
| 33894194 | Advances in neuroimaging to improve care in sickle cell disease. | Lancet Neurol | 2021 |
| 33840223 | Cerebral Hemodynamics and Executive Function in Sickle Cell Anemia. | Stroke | 2021 |
| 34432719 | Academic Medicine's Journey Toward Racial Equity Must Be Grounded in History: Recommendations for Becoming an Antiracist Academic Medical Center. | Acad Med | 2021 |
| 34607344 | Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial. | Blood Adv | 2021 |
| 34397574 | Preliminary Study of Coping, Perceived Control, and Depressive Symptoms in Youth with Sickle Cell Anemia. | J Dev Behav Pediatr | 2021 |
| 34396363 | Identifying elevated risk for future pain crises in sickle-cell disease using photoplethysmogram patterns measured during sleep: A machine learning approach. | Front Digit Health | 2021 |
| 34563875 | Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa. | Pediatr Neurol | 2021 |
| 33984165 | Low FEV<sub>1</sub> is associated with fetal death in pregnant women with sickle cell disease. | Am J Hematol | 2021 |
| 34115136 | Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither. | Blood | 2021 |
| 34283174 | A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease. | Blood Adv | 2021 |
| 33027545 | Nocturnal peripheral vasoconstriction predicts the frequency of severe acute pain episodes in children with sickle cell disease. | Am J Hematol | 2021 |